Related Experiment Video
Updated: Oct 20, 2025
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.0K
Current Controversies in Neoadjuvant Therapy for Pancreatic Cancer
Erin P Ward1, Herbert J Zeh Iii2, Susan Tsai1
1Surgical Oncology Division, Department of Surgery, Medical College of Wisconsin, 8701 W Watertown Plank Road, Milwaukee, WI 53226, USA.
Surgical Oncology Clinics of North America
|September 13, 2021
Abstract:
Over the last two decades, there have been significant changes in the management of patients with localized pancreatic cancer. The rationale for an evolution toward a neoadjuvant approach and summary of relevant clinical trials is reviewed. Controversies in identifying optimal neoadjuvant therapeutic approaches are discussed.
